Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.

AIDS (London, England) - 23 Apr 2007

Gulick Roy M, Lalama Christina M, Ribaudo Heather J, Shikuma Cecilia M, Schackman Bruce R, Schouten Jeffrey, Squires Kathleen E, Koletar Susan L, Pilcher Christopher D, Reichman Richard C, Klingman Karin L, Kuritzkes Daniel R

Abstract excerpt

OBJECTIVE: To compare a quadruple-nucleoside with an efavirenz-containing regimen for treatment of HIV-1 infection. DESIGN: A randomized, open-label study of the AIDS Clinical Trials Group (ACTG). METHODS: Subjects receiving zidovudine/lamivudine/abacavir on ACTG 5095 with HIV-1 RNA less than 200 copies/ml were randomly assigned to intensify either with tenofovir or efavirenz. Subjects were followed for time to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alkynes
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Benzoxazines

Share to CD4 Lymphocyte Count

Share to Cyclopropanes

Share to Organophosphonates

Share to Patient Compliance

Share to Tenofovir

Source

Identifiers

PMID: 17415036
DOI: 10.1097/QAD.0b013e32805e8753

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.PMID 17415036Read ↗

A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen.Semantic proximity Read ↗

Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.Semantic proximity Read ↗

Intensification of treatment with pegylated interferon alfa in patients coinfected with HIV and HBV genotype H or G being treated with a tenofovir/emtricitabine-containing regimen.Semantic proximity Read ↗

Treatment Intensification with Raltegravir in Subjects with Sustained HIV-1 Viraemia Suppression: A Randomized 48-Week StudySemantic proximity Read ↗

Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.Semantic proximity Read ↗

A virological benefit from an induction/maintenance strategy: the Forte trial.Semantic proximity Read ↗

Quadruple nucleoside therapy with zidovudine, lamivudine, abacavir and tenofovir in the treatment of HIV.Semantic proximity Read ↗

Salvage therapy with atazanavir/ritonavir combined to tenofovir in HIV-infected patients with multiple treatment failures: randomized ANRS 107 trial.Semantic proximity Read ↗

Abacavir for salvage or intensification.Semantic proximity Read ↗

Early virological failure after tenofovir + didanosine + efavirenz combination in HIV-positive patients upon starting antiretroviral therapy.Semantic proximity Read ↗

Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS study.Semantic proximity Read ↗

Early virological failure with a combination of tenofovir, didanosine and efavirenz.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.